Abamune Abacavir 300 mg Tablet

Q1: What is Abamune (Abacavir 300mg) used for?

Abamune is a branded formulation of Abacavir 300mg, an NRTI used as part of combination HIV-1 therapy. It is used to suppress viral replication, restore CD4 cell counts, and prevent progression to AIDS when combined with other antiretrovirals.

Q2: How does Abamune compare to generic Abacavir formulations?

Abamune contains the same active pharmaceutical ingredient (Abacavir sulphate) as generic Abacavir, with equivalent therapeutic efficacy. The manufacturing quality standards may differ — Abamune is manufactured by Cipla, a globally recognized pharmaceutical company.

Q3: What is the HLA-B*5701 requirement for Abamune?

HLA-B*5701 genetic testing is mandatory before starting any Abacavir product including Abamune. Patients positive for this allele have a high risk of severe hypersensitivity reaction and must not receive Abacavir.

Q4: What is the dosing schedule for Abamune?

Standard dosing: 300mg twice daily (morning and evening) or 600mg once daily. Once-daily dosing reduces pill burden and may improve adherence. Take consistently at the same time(s) each day, with or without food.

Q5: What is the Abacavir hypersensitivity reaction?

A multi-system reaction in 2–8% of patients, causing fever, skin rash, nausea, vomiting, fatigue, and respiratory symptoms — usually within the first 6 weeks. Stop Abamune IMMEDIATELY and seek medical care. Never rechallenge — reexposure can cause fatal hypotension.

Q6: What are the most common side effects of Abamune?

Nausea, vomiting, diarrhea, fatigue, and headache are most common early in treatment. Most GI side effects improve within 2–4 weeks. Persistent or new symptoms in the first 6 weeks must be evaluated for HSR.

Q7: Can Abamune be used in HIV/HBV co-infected patients?

Abacavir is not active against hepatitis B virus. HIV/HBV co-infected patients require an HBV-active NRTI (Tenofovir or Lamivudine) in their regimen. Switching from Abamune-containing regimens without HBV-active coverage can cause HBV flares.

Q8: What is the cardiovascular consideration with Abamune?

Some observational data suggest Abacavir may increase cardiovascular risk, particularly in patients with pre-existing heart disease. This is not a class-wide NRTI effect — your HIV specialist will weigh the benefits and risks for your individual cardiovascular risk profile.

Q9: Can Abamune be used during pregnancy?

Abacavir can be used in pregnancy after HLA-B*5701 testing confirms safety. It appears in some HIV-in-pregnancy treatment guidelines. The full antiretroviral regimen should be planned jointly by an HIV and obstetric specialist.

Q10: What monitoring is needed during Abamune treatment?

CD4 count and viral load at baseline then every 3–6 months. Liver function tests at baseline and periodically. Careful HSR monitoring in the first 6 weeks. Lipid and cardiovascular risk assessment if relevant.

Q11: How should Abamune 300mg be stored?

Store at room temperature away from direct light and moisture. Keep in original packaging. Keep out of reach of children. Do not use after the expiry date.

Q12: Do I need a prescription for Abamune?

Yes. Abamune requires specialist HIV prescribing with mandatory HLA-B*5701 pre-testing and ongoing viral load monitoring to ensure therapeutic success.